Mascoma Wealth Management’s Biogen BIIB Stock Holding History

Mascoma Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$200K	Hold	927	–	–	0.04%	94
2026 Q1	$170K	Buy	927 +2	+0.2%	+$369	0.04%	104
2025 Q4	$163K	Hold	925	–	–	0.03%	102
2025 Q3	$130K	Hold	925	–	–	0.03%	116
2025 Q2	$116K	Sell	925 -2	-0.2%	-$249	0.03%	118
2025 Q1	$127K	Hold	927	–	–	0.03%	117
2024 Q4	$142K	Buy	927 +2	+0.2%	+$337	0.04%	111
2024 Q3	$179K	Hold	925	–	–	0.04%	98
2024 Q2	$214K	Hold	925	–	–	0.06%	92
2024 Q1	$199K	Hold	925	–	–	0.06%	95
2023 Q4	$239K	Hold	925	–	–	0.07%	90
2023 Q3	$238K	Hold	925	–	–	0.07%	91
2023 Q2	$254K	Sell	925 -9	-1%	-$2.68K	0.08%	88
2023 Q1	$284K	Buy	934 +925	+10,278%	+$256K	0.08%	96
2022 Q4	$2.49K	Hold	9	–	–	﹤0.01%	554
2022 Q3	$2K	Hold	9	–	–	﹤0.01%	552
2022 Q2	$2K	Hold	9	–	–	﹤0.01%	562
2022 Q1	$2K	Hold	9	–	–	﹤0.01%	550
2021 Q4	$2K	Hold	9	–	–	﹤0.01%	494
2021 Q3	$3K	Buy	+9	New	+$2.95K	﹤0.01%	402
2021 Q2	–	Sell	-9	Closed	-$3K	–	137
2021 Q1	$3K	Buy	+9	New	+$2.43K	﹤0.01%	399
2017 Q3	–	Sell	-40	Closed	-$11K	–	398
2017 Q2	$11K	Buy	+40	New	+$10.6K	0.01%	277

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mascoma Wealth Management's BIIB Position: Q2 2026 in Review

Mascoma Wealth Management held its Biogen (BIIB) position steady in Q2 2026 at 927 shares worth $200K. The position accounts for 0.04% of the portfolio, ranked #94.

Mascoma Wealth Management first reported a position in BIIB in Q2 2017 and has held it in 22 quarters since. The position peaked at $284K in Q1 2023. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Mascoma Wealth Management held 927 shares of Biogen worth $200K as of Q2 2026.
Mascoma Wealth Management left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.04% of Mascoma Wealth Management's portfolio in Q2 2026, its #94 holding.
Mascoma Wealth Management first reported a position in Biogen in Q2 2017 and has held it in 22 quarters since.
Mascoma Wealth Management's Biogen position peaked at $284K in Q1 2023.
1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.